Showing results (251-260 of 301) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Oncology|October 1, 1983
Phase II study of PALA and AMSA in advanced renal cell carcinomaR H Earhart, P J Elson, S N Rosenthal, et al.
American Journal of Epidemiology|September 30, 1998
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish menS Carlsson, P G Persson, M Alvarsson, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 1, 1989
Clear cell odontogenic carcinoma: report of three cases with pulmonary and lymph node metastasesG Bang, H S Koppang, L S Hansen, et al.
Scandinavian Journal of Social Medicine|April 4, 1998
Food frequency questionnaire versus 7-day weighed dietary record information on dietary fibre and fat intake in middle-aged Swedish menP G Persson, S Carlsson, V Grill, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Differences in risk factor patterns between cervical and trochanteric hip fractures. Swedish Hip Fracture Study GroupK Michaëlsson, E Weiderpass, B Y Farahmand, et al.
American Journal of Clinical Oncology|August 1, 1987
A randomized clinical trial of combination chemotherapy in advanced colorectal cancerM J O'Connell, A J Schutt, C G Moertel, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot studyR H Earhart, C Moertel, R G Hahn, et al.
Cancer|November 15, 1980
Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experienceE Z Ezdinli, R Gelber, D V Desai, et al.
BMJ (Clinical Research Ed.)|June 19, 1998
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study GroupK Michaëlsson, J A Baron, B Y Farahmand, et al.
Cancer|January 15, 1993
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the eastern Cooperative Oncology GroupL I Gordon, J Andersen, S Gregory, et al.
Pageof 31